These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1506343)

  • 41. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
    Zullo A; Cristofari F; Hassan C
    Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
    [No Abstract]   [Full Text] [Related]  

  • 42. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 43. [Importance of ranitidine in the eradication of Helicobacter pylori].
    Beglinger C
    Rev Med Suisse Romande; 1995 Oct; 115(10):795-7. PubMed ID: 7501932
    [No Abstract]   [Full Text] [Related]  

  • 44. [Indications for therapy against Helicobacter pylori].
    Seensalu R; Glise H; Nyrén O
    Lakartidningen; 1994 May; 91(19):1927-8. PubMed ID: 8189939
    [No Abstract]   [Full Text] [Related]  

  • 45. "Modern therapies for Helicobacter pylori infection".
    Go MF
    Acta Gastroenterol Latinoam; 1996; 26(2):119-23. PubMed ID: 9137668
    [No Abstract]   [Full Text] [Related]  

  • 46. Peptic ulcer disease: let's help cure it.
    Weart CW
    J Am Pharm Assoc (Wash); 2000; 40(4):560-1. PubMed ID: 10932467
    [No Abstract]   [Full Text] [Related]  

  • 47. [Microbiocenosis of the bowels in patients with gastroduodenal ulcers].
    Butov MA; Karpova EIu
    Eksp Klin Gastroenterol; 2004; (2):22-4, 108. PubMed ID: 15462314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
    Tovar-Calderón S; Casaubón-Garcín P; Ramírez-Mayans J; Cervantes R
    Bol Med Hosp Infant Mex; 1991 Oct; 48(10):743-8. PubMed ID: 1764199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 51. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1994 Jul; 36(927):65-7. PubMed ID: 7912812
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of Helicobacter pylori.
    Harris A
    World J Gastroenterol; 2001 Jun; 7(3):303-7. PubMed ID: 11819780
    [No Abstract]   [Full Text] [Related]  

  • 53. Helicobacter pylori and peptic ulcer disease.
    Bonney RC
    Am Clin Lab; 1998 Mar; 17(2):4. PubMed ID: 10178670
    [No Abstract]   [Full Text] [Related]  

  • 54. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
    Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
    [No Abstract]   [Full Text] [Related]  

  • 55. H. pylori: scientific basis to patient cure.
    Peura DA
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():31-3. PubMed ID: 17037765
    [No Abstract]   [Full Text] [Related]  

  • 56. Helicobacter pylori and ulcer in patients taking NSAIDs.
    Berkelhammer C
    JAMA; 1995 Feb; 273(5):376. PubMed ID: 7823378
    [No Abstract]   [Full Text] [Related]  

  • 57. [Choice of therapy (Helicobacter infection)].
    Danielsson A; Jaup B; Unge P
    Lakartidningen; 1994 May; 91(19):1928-30. PubMed ID: 8189940
    [No Abstract]   [Full Text] [Related]  

  • 58. [The several problems and cautions in treatment of Helicobacter pylori infection].
    Fukuda Y; Sakagami T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1465-74. PubMed ID: 15508434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
    Gabryelewicz A
    J Physiol Pharmacol; 1996 Mar; 47(1):51-8. PubMed ID: 8777307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ASHP therapeutic position statement on the identification and treatment of Helicobacter pylori-associated peptic ulcer disease in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 11, 2000.
    ASHP Commission on Therapeutics. ASHP Board of Directors
    Am J Health Syst Pharm; 2001 Feb; 58(4):331-7. PubMed ID: 11225171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.